503B Manufacturer for Veterinary Medications & Animal Health

Notice for California Patients

epicur logo
epicur logo

Dr. Mark Byrum, Veterinary Oncologist: A Veterinary Perspective on Chemo Tablet Benefits

Like & Share
Tweet
Share
Veterinary Oncology interview with Dr. Mark Byrum

Dr. Mark Byrum, a veterinary oncologist understands that each patient requires a unique approach and individualized care. He also knows that the highest care in a critical specialty like oncology comes from safe, high-quality drugs. As a veterinarian who prescribes Epicur chemo tablets, we asked him to share his perspective on what makes the blister packs and our 503B manufactured drugs the best option for his patients.

We were also excited to talk with him about what led him to this specialty, the trends he is seeing in veterinary medicine, and what he’s looking forward to in his new role. If you have ever met Mark, you know his energy and love for veterinary oncology are contagious – this conversation is worth the watch! Plus, his pup Brutus makes a guest appearance!

More Oncology Resources

Another Expert’s Perspective:

Learn more about the benefits of chemo blister packs from Advisory Council member and Veterinary Oncologist, Phil Bergman. Read the blog!

Sign up for updates.

Get the latest posts and Epicur updates direct to your inbox.

Sign Me Up
Featured Posts:

The Referral Dilemma: Choosing the Best Partners in Veterinary Medicine

The following blog is written by Epicur Pharma’s Advisory Council member Debbie Boone, BS, CVPM. With over 23 years of in-clinic experience managing AAHA-accredited hospitals, Debbie understands the processes and systems a thriving practice must have in place – and what it takes to implement them. Debbie shares her perspective on referrals, and how veterinary professionals can ensure integrity and reliability through careful selection of the companies they utilize and endorse for crucial medications.

Read More »

Innovating Pain Management in Veterinary Research Medicine

Epicur Pharma recently partnered with two passionate veterinary research professionals, Dr. Daniel D. Myers Jr., DVM, MPH, DACLAM, and Dr. Patrick A. Lester, DVM, MS, BCPS, DACLAM, to bring a groundbreaking analgesic solution to market for research animals: Buprenorphine Extended Release. We sat down with them to reflect on their path to partnering with us and their hopes for the future of veterinary medicine.

Read More »